Published in J Exp Med on April 01, 1982
The forgotten tale of immunoglobulin allotypes in cancer risk and treatment. Exp Hematol Oncol (2013) 0.91
Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer. Hum Immunol (2010) 0.88
Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Clin Exp Immunol (2014) 0.82
A genetic variant of FcγRIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics (2012) 0.80
Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma. Neuro Oncol (2014) 0.76
Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. J Clin Invest (1986) 0.75
The investigation of linkage between a quantitative trait and a marker locus. Behav Genet (1972) 24.92
Disease susceptibility genes--their identification by multiple case family studies. Tissue Antigens (1976) 5.17
Role of MHC gene products in immune regulation. Science (1981) 4.84
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol (1980) 2.12
Cultivation in vitro of cells derived from a human osteosarcoma. Cancer (1971) 2.06
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67
IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus. N Engl J Med (1981) 1.57
Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol (1981) 1.43
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27
Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis. J Exp Med (1980) 1.23
A membrane antigen common to human cancer and fetal brain tissues. Cancer Res (1976) 1.19
Tumor-specific cell-mediated immunity in household contacts of cancer patients.. J Clin Invest (1975) 1.04
Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer. J Natl Cancer Inst (1981) 1.00
Uncommon Gm phenotypes in sera from neuroblastoma patients. J Immunol (1977) 0.95
HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Hum Immunol (1981) 0.93
Placenta-like alkaline phosphatases from human osteosarcoma cells. Cancer Res (1978) 0.84
Osteogenic sarcoma in siblings. Johns Hopkins Med J (1979) 0.81
Serogenetic investigations on malignant melanomas with reference to the incidence of ABO system, Rh system, Gm, Inv, Hp and Ge systems. Humangenetik (1972) 0.79
Isolation and partial purification of plasma membrane-associated antigens from human osteosarcoma (TE-85) cells in tissue culture. Cancer Res (1976) 0.79
Immunologic studies in contacts of osteosarcoma in humans and animals. Nature (1977) 0.79
Osteosarcoma in siblings. Report of two cases. J Bone Joint Surg Am (1977) 0.78
Osteosarcoma patients: isolation of serum antibodies by affinity chromatography. J Natl Cancer Inst (1981) 0.78
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol (1967) 7.30
Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10
The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest (1973) 4.69
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
Isolation of normal T cells in chronic lymphatic leukaemia. Lancet (1973) 3.95
Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A (1970) 2.89
A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40
Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med (1966) 2.33
Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation. Development (2001) 2.33
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clin Cancer Res (2000) 2.28
Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease. Science (1971) 2.27
Peyer's patches: morphologic studies. Cell Immunol (1970) 2.08
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med (1973) 2.02
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res (2001) 2.01
The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol (1974) 1.94
In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen. J Natl Cancer Inst (1997) 1.92
Immunohistological and elution studies of the human placenta. J Exp Med (1971) 1.88
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82
The occurrence of antibodies to collagen in synovial fluids. Clin Immunol Immunopathol (1975) 1.74
"Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins. J Immunol (1969) 1.74
Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. J Clin Endocrinol Metab (1995) 1.72
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67
Rosette formation, a test for cellular immunity. Trans Assoc Am Physicians (1971) 1.64
Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62
Macroglobulinemia: an analysis for forty patients. Blood (1972) 1.61
Anionic sites on the membrane intercalated particles of human erythrocyte ghost membranes. Freeze-etch localization. Exp Cell Res (1973) 1.58
The identity of light chains of monoclonal IgG and monoclonal IgM in one patient. Immunochemistry (1969) 1.58
Impaired renal acidification in patients with hypergammaglobulinemia. Medicine (Baltimore) (1967) 1.55
Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res (2000) 1.52
Thymus-derived rosette-forming cells. N Engl J Med (1973) 1.50
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum (1998) 1.45
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. J Infect Dis (1986) 1.43
Selective absence of IgA: a family study. J Lab Clin Med (1968) 1.43
Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I. J Immunol (1980) 1.42
Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39
Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor. J Immunol Methods (1977) 1.39
Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39
Discussion paper: cross-reactivity of primate immunoglobulins. Ann N Y Acad Sci (1969) 1.38
Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production. J Exp Med (1972) 1.37
A new serum factor in normal rabbits. I. Identification and characterization. J Immunol (1965) 1.37
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. N Engl J Med (1986) 1.36
Genetically determined immune deficiency as the predisposing cause of "autoimmunity" and lymphoid neoplasia. Am J Med (1971) 1.36
Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein. J Exp Med (1970) 1.34
Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry (1970) 1.34
Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Cancer Res (1997) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30
RElation of the human antibody response to flagellin to GM genotype. J Immunol (1971) 1.30
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med (1997) 1.29
Effect of prednisolone on synthesis of DNA and RNA by human lymphocytes in vitro. Nature (1967) 1.29
Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest (1984) 1.28
Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nat New Biol (1973) 1.28
Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28
Immunologic deficiency, autoimmune disease, and lymphoma: observations, implications, and speculations. Arthritis Rheum (1966) 1.27
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
Peyer's patches: immunologic studies. J Exp Med (1970) 1.26
Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril (1987) 1.24
Humoral immunity in vaginal candidiasis. Infect Immun (1977) 1.24
Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315. Proc Natl Acad Sci U S A (1973) 1.24
Quantitative studies of phytohemagglutinin-induced DNA and RNA synthesis in normal and agammaglobulinemic leukocytes. J Exp Med (1967) 1.23
On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry (1965) 1.23
Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinemia. Am J Med (1967) 1.22
Template-nucleated alanine-lysine helices are stabilized by position-dependent interactions between the lysine side chain and the helix barrel. Proc Natl Acad Sci U S A (1996) 1.22
Editorial: T-rosette forming cells, cellular immunity and cancer. N Engl J Med (1975) 1.22
Characterization of macrophage agglutinating factor as a hyaluronic acid-protein complex. J Reticuloendothel Soc (1979) 1.21
Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement. J Immunol (1969) 1.21
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect (1999) 1.20
Nucleotide sequence of a new BALB/c mouse kappa light chain variable region gene. Nucleic Acids Res (1990) 1.20
Passive immune lysis with chromic chloride-treated erythrocytes. J Immunol (1969) 1.20
Further studies on the pathogenesis of rheumatoid joint inflammation. Arthritis Rheum (1966) 1.19
A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19
Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation. J Immunol (1975) 1.19
Disorders of neutrophil function. Defects in the early stages of the phagocytic process. Clin Exp Immunol (1973) 1.18
Unusual disease of pulmonary arteries with dyspnea. Structure-function relationships. Am J Med (1966) 1.18
The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications. J Immunol (1980) 1.17
Genes associated with the G2m(23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis (1988) 1.16
Transfer factor therapy in immune deficiency states. Annu Rev Med (1973) 1.16
Cellular immunity to platelets in idiopathic thrombocytopenic purpura. Blood (1972) 1.16
The immune globulins. Annu Rev Microbiol (1965) 1.15
A genetic defect in "acquired" agammaglobulinemia. Proc Natl Acad Sci U S A (1968) 1.15
Rheumatoid factors and the etiology of rheumatoid arthritis. Ann N Y Acad Sci (1965) 1.13
Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets. Eur J Immunol (1985) 1.13
Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifugation. Blood (1980) 1.12
Thymosin: effects on normal human blood T-cells. Ann N Y Acad Sci (1975) 1.12
A selective neutrophil dysfunction syndrome: impaired killing of staphylococci. Ann Intern Med (1968) 1.12